Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Veterinary Research|April 5, 2021
Clinical Use of The Parasympathetic Tone Activity Index As a Measurement of Postoperative Analgaesia in Dogs Undergoing OvariohysterectomyIsmael Hernández-Avalos, Alex Valverde, José Antonio Ibancovichi-Camarillo, et al.
British Journal of Haematology|January 19, 2018
Hypoalbuminaemia segregates different prognostic subgroups within the refined standard risk acute graft-versus-host disease scoreMohamed A Kharfan-Dabaja, Kyle Sheets, Ambuj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid LeukemiaKendra Sweet, Rami Komrokji, Eric Padron, et al.
Hematological Oncology|August 3, 2026
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T-Cell LymphomaHayder Saeed, Melanie Mediavilla Varela, Eva Sahakian, et al.
Transplantation and Cellular Therapy|December 29, 2024
Real-World Patient-Reported and Neurocognitive Outcomes in the Year After Axicabtagene CiloleucelAasha I Hoogland, Xiaoyin Li, Karnav Modi, et al.
Blood Immunology & Cellular Therapy|July 8, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CARTKunhwa Kim, Zachary Hunzeker, Xiaowen Sun, et al.
Transplantation and Cellular Therapy|May 13, 2024
Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell LymphomaYumeng Zhang, Ashley Rose, Sushmita Khadka, et al.
Bone Marrow Transplantation|November 17, 2023
Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapyMadiha Iqbal, Deepa Jagadeesh, Julio Chavez, et al.
Cardio-Oncology (London, England)|April 3, 2023
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory studyDae Hyun Lee, Sanjay Chandrasekhar, Michael D Jain, et al.
British Journal of Haematology|December 22, 2017
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysisNirav N Shah, Aniko Szabo, Scott F Huntington, et al.
Pageof 5